BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
Keyword: Mammalian target of rapamycin inhibitors
1
Mammalian target of rapamycin; novel insight for management of inflammatory bowel diseases
1/25/2022 7:27:40 AM | Browse: 671 | Download: 1629
2
Systemic meta-analysis assessing the short term applicability of early conversion to mammalian target of rapamycin inhibitors in kidney transplant
4/20/2017 8:08:00 PM | Browse: 1186 | Download: 2247
3
Organ transplantation and drug eluting stents: Perioperative challenges
12/14/2016 2:15:00 PM | Browse: 963 | Download: 1355
4
Recurrence of lymphangioleiomyomatosis: Nine years after a bilateral lung transplantation
3/18/2016 2:28:00 PM | Browse: 906 | Download: 1645
5
Twelve-month efficacy and safety of the conversion to everolimus in maintenance heart transplant recipients
12/23/2015 8:26:00 AM | Browse: 1195 | Download: 2266
6
Hepatocellular carcinoma: A comprehensive review
11/18/2015 11:12:00 AM | Browse: 1515 | Download: 2103
7
Conversion from calcineurin inhibitors to mTOR inhibitors stabilizes diabetic and hypertensive nephropathy after liver transplant
3/24/2015 5:37:00 PM | Browse: 1121 | Download: 1729
8
Hepatitis B reactivation related to everolimus
9/10/2014 3:18:00 PM | Browse: 1071 | Download: 712
9
“Targeting” renal cell carcinoma patients with “targeted” agents: Are we there yet?
9/3/2014 10:06:00 AM | Browse: 927 | Download: 1103